Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Apoptosis
    (1)
  • VEGFR
    (1)
  • c-Met/HGFR
    (3)
Filter
Search Result
Results for "

mgcd 265

" in TargetMol Product Catalog
  • Inhibitors & Agonists
    3
    TargetMol | Activity
MGCD-265 analog
MGCD-265,Glesatinib analog
T6351875337-44-3
MGCD-265 analog (Glesatinib) is an orally bioavailable multitargeted tyrosine kinase inhibitor with potential antineoplastic activity with IC50 of 29 nM and 10 nM for c-Met and VEGFR2, respectively.
  • Inquiry Price
Size
QTY
TargetMol | Inhibitor Sale
Glesatinib
MGCD265
T15384936694-12-1
Glesatinib is an orally active and potent dual inhibitor of MET/SMO. Glesatinib is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
  • Inquiry Price
6-8 weeks
Size
QTY
Glesatinib hydrochloride
MGCD265 hydrochloride
T153831123838-51-6
Glesatinib hydrochloride is an orally active and potent dual inhibitor of MET/SMO. Glesatinib hydrochloride is also a tyrosine kinase inhibitor. It antagonizes P-glycoprotein mediated multidrug resistance (MDR) in NSCLC.
  • Inquiry Price
6-8 weeks
Size
QTY